Celldex Therapeutics Inc (NASDAQ:CLDX)

0.711
Delayed Data
As of Apr 24
 +0.0238 / +3.46%
Today’s Change
0.65
Today|||52-Week Range
3.42
-74.96%
Year-to-Date

Today’s Trading

Previous close0.69
Today’s open0.71
Day’s range0.67 - 0.72
Volume3,790,780
Average volume (3 months)2,076,448
Market cap$397.8M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+43.31%
Earnings growth (this year)-10.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.78%
P/E ratioNM
Price/Sales28.65
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.02+0.32%
OXFDOxford Immunotec Glo...-0.04-0.32%
QTNTQuotient Ltd0.000.00%
TRIBTrinity Biotech PLC-0.06-1.23%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$12.7M
Annual profit (last year)-$93.0M
Net profit margin-730.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts